Interactions of acetylcholinesterase with caveolin-1 and subsequently with cytochrome c are required for apoptosome formation

Carcinogenesis

Volumn 29, Issue 4, 2008, Pages 729-737

  Park, Sang Eun ^a,b   Jeong, Seung Hun ^a   Yee, Soo Bog ^a   Kim, Tae Hyun ^a   Soung, Young Hwa ^a   Ha, Nam Chul ^b   Kim, Nam Deuk ^b   Park, Jae Yong ^c   Bae, Hae Rahn ^a   Park, Bong Soo ^b   Lee, Hye Jeong ^a   Yoo, Young Hyun ^a  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CAVEOLIN 1; CYTOCHROME C; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAVEOLA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ACETYLCHOLINESTERASE; APOPTOSIS; BASE SEQUENCE; CAVEOLIN 1; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; CYTOCHROMES C; DNA PRIMERS; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SULINDAC; TRANSFECTION;

EID: 41849089728     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn036     Document Type: Article

References (30)

1. Small,D.H. et al. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int., 28, 453-483.
2. Wright,C.I. et al. (1993) Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease. Ann. N. Y. Acad Sci., 695, 65-68.
3. Salmon,A.Y. et al. (1999) Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine. Clin. Exp. Pharmacol. Physiol., 26, 596-600.
4. Checler,F. (1990) Non-cholinergic actions of acetylcholinesterases: A genuine peptidase function or contaminating proteases? Trends Biochem Sci., 15, 337-338.
5. Jayanthi,L.D. et al. (1992) Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid. Clin. Chim. Acta, 205, 157-166.
6. Taylor,P. et al. (1994) The cholinesterases: From genes to proteins. Annu. Rev. Pharmacol. Toxicol., 34, 281-320.
7. Zeng,W.R. et al. (1999) Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene. Oncogene, 18, 2015-2021.
8. Takahashi,S. et al. (1995) Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55, 4114-4119.
9. Dich,J. et al. (1997) Pesticides and cancer. Cancer Causes Control, 8, 420-443.
10. Zhang,X.J. et al. (2002) Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ 9, 790-800.
11. Deng,R. et al. (2006) Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Oncogene, 53, 7070-7077.
12. Park,S.E. et al. (2004) Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res., 64, 2652-2655.
13. Ekert,P.G. et al. (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol., 165, 835-842.
14. Li,P. et al. (1997) Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic-protease cascade. Cell, 91, 479-489.
15. Kuwana,T. et al. (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell, 111, 331-342.
16. Rudner,J. et al. (2005) Type I and type II reactions in TRAIL-induced apoptosis-results from dose-response studies. Oncogene 24, 130-140.
17. Qin,H. et al. (1999) Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature, 399, 549-559.
18. Chau,B.N. et al. (2000) Aven, a novel inhibitor of caspase activation, binds Bcl-xL and apaf-1, Mol. Cell, 6, 31-40.
19. Bratton,S.B. et al. (2001) Recruitment, activation and retention of caspases-9 and -3 byApaf-1 apoptosome and associated XIAP complexes. EMBO J., 20, 998-1009.
20. Ferrando-May,E. (2005) Nucleocytoplasmic transport, in apoptosis. Cell Death Differ, 12, 1263-1276.
21. Jin,Q.H. et al. (2004) Overexpression of acetylcholinesterase inhibited and promoted apoptosis in NRK cells. Acta Pharmacol. Sin. 8, 1013-1021.
22. Perry,C. et al. (2002) Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene, 21, 8428-8441.
23. Razani,B. et al. (2002) Caveolae: From cell biology to animal physiology. Pharmacol. Rev., 54, 431-467.
24. Galbiati,F. et al. (2001) Emerging themes in lipid rafts and caveolae. Cell, 106, 403-411.
25. Torres,V.A. et al. (2006) Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J. Cell Sci., 119, 1812-1823.
26. Couet,J. et al. (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem., 272, 6525-6533.
27. Zundel,W. et al. (2000) Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol. Cell. Biol., 20, 1507-1514.
28. Liu,J. et al. (2001) Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol., 280, C823-C835.
29. Podar,K. et al. (2003) Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells. J. Mol. Chem., 278, 5794-5901.
30. Li,L. et al. (2003) Caveolin-1 maintains activated-Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol. Cell. Biol., 23, 9389-9404.